Logo-apb
Adv Pharm Bull. 2023;13(3): 512-520. doi: 10.34172/apb.2023.062
PMID: 37646057        PMCID: PMC10460802

Mini Review

Drug Delivery of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) to Target Brain Tumors

Soheil Mehrdadi 1 * ORCID

Cited by CrossRef: 9


1- Mesut B, Al-Mohaya M, Gholap A, Yeşilkaya E, Das U, Akhtar M, Sah R, Khan S, Moin A, Faiyazuddin M. Demystifying the potential of lipid-based nanocarriers in targeting brain malignancies. Naunyn-Schmiedeberg's Arch Pharmacol. 2024; [Crossref]
2- Jawad M, Shafique U, Din F, Butt A, Khan S, Khan G, Alamri A, Lahiq A, Alsharif S, Almerai K. Nose to brain delivery of escitalopram-loaded nano-structured lipid carriers thermosensitive gel: Formulation, physiochemical, pharmacokinetic and pharmacodynamics evaluation. Journal of Drug Delivery Science and Technology. 2024;97:105800 [Crossref]
3- Peng X, Ma Y, Yan C, Wei X, Zhang L, Jiang H, Ma Y, Zhang S, Xing M, Gao Y. Mechanism, Formulation, and Efficacy Evaluation of Natural Products for Skin Pigmentation Treatment. Pharmaceutics. 2024;16(8):1022 [Crossref]
4- Arafat M, Sakkal M, Beiram R, AbuRuz S. Nanomedicines: Emerging Platforms in Smart Chemotherapy Treatment—A Recent Review. Pharmaceuticals. 2024;17(3):315 [Crossref]
5- Abu-Hdaib B, Nsairat H, El-Tanani M, Al-Deeb I, Hasasna N. In vivo evaluation of mebendazole and Ran GTPase inhibition in breast cancer model system . Nanomedicine. 2024;19(12):1087 [Crossref]
6- Wang H, Bo W, Feng X, Zhang J, Li G, Chen Y. Strategies and Recent Advances on Improving Efficient Antitumor of Lenvatinib Based on Nanoparticle Delivery System. IJN. 2024;Volume 19:5581 [Crossref]
7- Gao X, Ciura K, Ma Y, Mikolajczyk A, Jagiello K, Wan Y, Gao Y, Zheng J, Zhong S, Puzyn T, Gao X. Toward the Integration of Machine Learning and Molecular Modeling for Designing Drug Delivery Nanocarriers. Advanced Materials. 2024;36(45) [Crossref]
8- Li H, Guan M, Zhang N, Wang Y, Liang T, Wu H, Wang C, Sun T, Liu S. Harnessing nanomedicine for modulating microglial states in the central nervous system disorders: Challenges and opportunities. Biomedicine & Pharmacotherapy. 2024;177:117011 [Crossref]